Literature DB >> 23322909

Developing and pilot testing practical measures of preanalytic surgical specimen identification defects.

Paul J Bixenstine1, Richard J Zarbo, Christine G Holzmueller, Gayane Yenokyan, Raymond Robinson, Daniel W Hudson, Arlene M Prescott, Ron Hubble, Mary M Murphy, Chris T George, Rita D'Angelo, Sam R Watson, Lisa H Lubomski, Sean M Berenholtz.   

Abstract

Accurate patient identification is a National Patient Safety Goal. Misidentification of surgical specimens is associated with increased morbidity, mortality, and costs of care. The authors developed 12 practical, process-based, standardized measures of surgical specimen identification defects during the preanalytic phase of pathology testing (from the operating room to the surgical pathology laboratory) that could be used to quantify the occurrence of these defects. The measures (6 container and 6 requisition identification defects) were developed by a panel of physicians, pathologists, nurses, and quality experts. A total of 69 hospitals prospectively collected data over 3 months. Overall, there were identification defects in 2.9% of cases (1780/60 501; 95% confidence interval [CI] = 2.0%-4.4%), 1.2% of containers (1018/81 656; 95% CI = 0.8%-2.0%), and 2.3% of requisitions (1417/61 245; 95% CI = 1.2%-4.6%). Future research is needed to evaluate if hospitals are able to use these measures to assess interventions meant to reduce the frequency of specimen identification defects and improve patient safety.

Entities:  

Keywords:  identification errors; labeling errors; quality measures; surgical pathology; surgical specimens

Mesh:

Year:  2013        PMID: 23322909     DOI: 10.1177/1062860612469824

Source DB:  PubMed          Journal:  Am J Med Qual        ISSN: 1062-8606            Impact factor:   1.852


  1 in total

1.  The feasibility of computer-aided monitoring of the workflow in surgical pathology: a five-year experience.

Authors:  Chih-En Tseng; Hsiu-Huei Chiang; Liang-Yu Shih; Kai-Sheng Liao
Journal:  J Med Syst       Date:  2014-02-04       Impact factor: 4.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.